News
WALTHAM, MA — May 04, 2021 /PRNewswire/ — CorEvitas℠, the leading sponsor of registries in autoimmune and immune-mediated diseases, announced it has enrolled over 15,000 patients with immune-mediated skin diseases in the CorEvitas registries for moderate to severe psoriasis and atopic dermatitis (...Learn More
News
Ray Hill grew up on a farm and took up rowing in college. So he’s always been a hard worker and an early riser. In this edition of the HealthBiz podcast, Ray brings us up to date on progress at CorEvitas. As CEO and Chairman he’s led the company’s expansion from a singular rheumatoid arthritis...Learn More
News
WALTHAM, MA and BEVERLY HILLS, CA — March 30, 2021 /PRNewswire/ CorEvitas and The Guthy-Jackson Charitable Foundation (GJCF) are excited to announce plans for launching the SPHERES ( S ynergy of P rospective H ealth & E xperimental R esearch for E merging S olutions in NMOSD) Registry for...Learn More
News
Waltham, MA and London, UK, March 16, 2021—Michael Weintraub, Co-Founder and Managing Partner of Ardan Equity (“Ardan”), has joined the CorEvitas board of directors. CorEvitas [kohr-eh'-vi-tahs], formerly known as Corrona, LLC, is a built-for-purpose provider of gold-standard real-world evidence,...Learn More